ClinicalTrials.gov
ClinicalTrials.gov Menu

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00064129
Recruitment Status : Completed
First Posted : July 9, 2003
Last Update Posted : April 10, 2018
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 5, 2011
  Actual Study Completion Date : February 9, 2011